Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 583 results found. Search for [ All India Institute of Medical Sciences ]

Results 1 to 21 of 583
BusinessToday.In
April 9, 2021
The national capital reported 7,437 new positive cases on Thursday, with positivity rate at 8.10 per cent. Active cases in Delhi stood at 23,181.


BusinessToday.In
April 8, 2021
Coronavirus vaccination centres in Delhi: Here's the complete list of government Covid vaccination centres in all Delhi districts. COVID-19 vaccine is being administered for free at government facilities.


BusinessToday.In
April 8, 2021
Prime Minister Modi got the second dose of the coronavirus vaccine today at AIIMS; the first shot of the life-saving jab was administered to the PM on March 1


BusinessToday.In
April 2, 2021
Dr Randeep Guleria said young people are more affected this time and the severity of symptoms among them is lesser. However, he warned that the young people could transmit the virus to the elderly, which will further swamp the health infrastructure


PTI
March 23, 2021
Replying to supplementaries during the Question Hour, Health Minister Harsh Vardhan said in 2003, there was only one All India Institute of Medical Sciences (AIIMS) in the country in Delhi


PTI
March 21, 2021
According to the hospital, Birla (58) tested positive for the coronavirus infection on March 19. He was admitted to the AIIMS COVID Centre for observation the next day


BusinessToday.In
March 12, 2021
NEET 2021 date announced: The online application process for National Eligibility cum Entrance Test will begin shortly


BusinessToday.In
March 8, 2021
Muthoot Finance share price declined as much as 6.57 per cent in opening deals to hit low of Rs 1,205 as investors reacted to sudden demise of MG George Muthoot, the chairman of the company


BusinessToday.In
March 7, 2021
The AIIMS forensic team will start the assessment on Monday. \"We will be able to arrive at a conclusion within a week or 10 days,\" said Dr Sudhir Kumar Gupta, professor and head of the department of forensic medicine, AIIMS


BusinessToday.In
March 7, 2021
If savings being affected by Janaushadhi, Ayushman Bharat and decline in prices of drugs and stents are collated -- if we only take government schemes in the health sector -- poor and middle-income groups are saving around Rs 50,000 crore per year, says PM Modi


BusinessToday.In
March 4, 2021
In order to ramp up the COVID-19 vaccination capacity, the government is involving a large number of private facilities. The health ministry had said that around 10,000 hospitals under Ayushman Bharat-PMJAY and 687 hospitals under CGHS can be used as CVCs


BusinessToday.In
March 4, 2021
Indian Institute of Technology-Bombay has secured an overall ranking of 49 followed by IIT-Delhi at 54 and IIT-Madras at 94


BusinessToday.In
New Delhi, March 1, 2021
Prime Minister Narendra Modi on Monday took the first dose of COVID-19 vaccine at the All India Institute of Medical Sciences (AIIMS), Delhi as the country gets ready to expand its nationwide vaccination drive against coronavirus to drive down infections. This drive is for people above the age of 60 and those above 45 with comorbidities. PM Narendra Modi was administered home-grown 'Covaxin' by Bharat Biotech. In the current phase, eligible citizens can register and book an appointment for vaccination, anytime and anywhere, using the Co-WIN 2.0 portal or through the Aarogya Setu app. Watch the video for more.Also Read: Phase 2 COVID-19 vaccination: Are you eligible and how to register?


BusinessToday.In
March 1, 2021
The government, in this phase, will vaccinate people over 60 and individuals over 45 with comorbidities to rein in the rising number of more infectious virus strains leading to a spurt in COVID-19 cases in some states


BusinessToday.In
March 1, 2021
Prime Minister Narendra Modi was administered Bharat Biotech's Covaxin by Sister Nivedita from Puducherry


PTI
February 22, 2021
The company, which has its labs in England, had in early September 2020 received the approval from the Drug Controller General (DCGI) to conduct the phase 2 clinical trial of GPP-Baladol in patients with moderate infection of the pandemic with oxygen support


PTI
February 20, 2021
Speaking at an AIMA event here, Guleria said the vaccine is the only weapon available to gain immunity and help reduce mortality rate due to the infectious disease


Rashi Bisaria
New Delhi, February 18, 2021
South African variant could significantly reduce vaccine protection, says Pfizer A laboratory study suggests that the South African variant of the coronavirus may reduce antibody protection from the Pfizer-BioNTech vaccine by two-thirds, and it is not clear if the shot will be effective against the mutation, the companies said on Wednesday. Companies are making investments and talking to regulators about developing an updated version of their mRNA vaccine or a booster shot, if needed. COV...


BusinessToday.In
February 17, 2021
Saying that vaccination is necessary to fight the pandemic, Guleria urged people to not be afraid of the vaccine as it is totally safe.


PB Jayakumar
February 17, 2021
Coronavirus in India: The new facility will have a capacity to manufacture up to 10 million tests every month. CoviPath COVID-19 RT-PCR Kit has been approved by the ICMR and DCGI


PAGES 1 OF 30  12345